Suppression Benefits β-thalassemic Erythropoiesis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Transferrin Receptors in Erythropoiesis.
Richard C, Verdier F Int J Mol Sci. 2020; 21(24).
PMID: 33352721 PMC: 7766611. DOI: 10.3390/ijms21249713.
References
1.
Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C
. Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2004; 105(4):1803-6.
DOI: 10.1182/blood-2004-08-3042.
View
2.
Gardenghi S, Ramos P, Marongiu M, Melchiori L, Breda L, Guy E
. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest. 2010; 120(12):4466-77.
PMC: 2993583.
DOI: 10.1172/JCI41717.
View
3.
Artuso I, Lidonnici M, Altamura S, Mandelli G, Pettinato M, Muckenthaler M
. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model. Blood. 2018; 132(21):2286-2297.
PMC: 6302281.
DOI: 10.1182/blood-2018-05-852277.
View
4.
Wallace D, Secondes E, Rishi G, Ostini L, McDonald C, Lane S
. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction. Br J Haematol. 2014; 168(6):891-901.
DOI: 10.1111/bjh.13225.
View
5.
Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M
. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000; 25(1):14-5.
DOI: 10.1038/75534.
View